Japanese Political Powerhouse Joins Murad International Group—Taiwan-Japan Health & Biotech Collaboration Hits New Heights!
Tokyo, October 22, 2025 — Murad International Group proudly announces the appointment of former Japanese House of Councillors President Akiko Santō as the Group’s advisor. This landmark collaboration marks a new chapter in Taiwan-Japan cooperation in health and medical innovation, opening doors to regional advancements in regenerative medicine and biotech exchange.
Under the leadership of Dr. Chen Zhenxing, a pioneering figure in Asian health product research, Murad International Group has long championed science-driven health innovation. The Group brings together a cross-disciplinary research team with Nobel-level expertise, integrating pharmacology, nutrition, and functional medicine to develop safe, evidence-based health solutions.
Dr. Chen combines a deep academic background with profound insights into human health science, drawing inspiration from Nobel laureate Dr. Ferid Murad’s groundbreaking research in nitric oxide (NO). He continues to advance the translation of scientific discoveries into clinical applications, driving global health industry innovation.
Photo caption: Murad International Group Chairman Dr. Chen Zhenxing (right) and former Japanese House of Councillors President Akiko Santō (left) during the official appointment signing ceremony in Tokyo. Image: Murad International Group.
Murad International Group emphasizes that this collaboration stems from its long-standing commitment to research-driven initiatives and international cooperation.
Akiko Santō is one of Japan’s most iconic female political leaders. She began her public career as a TV host and actress before dedicating over half a century to public service. She has held positions as Minister of State, Director-General of the Science and Technology Agency, 27th Vice President, and 32nd President of the House of Councillors—one of the few Japanese women to combine executive and legislative experience. She has consistently championed public health and welfare policies, including the Basic Law on Food Education, the Passive Smoking Prevention Act, and the Food Waste Reduction Act.
Murad International Group stated that appointing Santō as advisor not only recognizes her profound impact in public policy and international affairs but also leverages her diplomatic and policy expertise to broaden the Group’s vision. Future collaboration will focus on regenerative medicine, exosome research, and health management, promoting cross-border academia-industry cooperation and regional innovation.
Aligned with the “Asian Regenerative Medicine Alliance” concept, both sides will advance clinical and academic partnerships, facilitate emerging technology applications, and harmonize international industry standards, fostering synergy between research and industry.
With aging populations and rising health demands, Murad International Group notes that biotechnology and regenerative medicine are critical to future healthcare. By leveraging Taiwan-Japan expertise and institutional exchange, the Group aims to establish an international platform integrating science, industry, and sustainability, positioning the region as a global hub for health innovation.
Santō’s appointment symbolizes the fusion of Japanese political wisdom with medical innovation, marking a pivotal step in Murad International Group’s global expansion. The Group remains committed to its mission of “connecting health through science, benefiting humanity through innovation,” working alongside international academic and industry partners to advance sustainable development in the health sector and usher in a new era of regenerative medicine.